cyclosporine has been researched along with Diabetic Retinopathy in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Bohley, M; Braunger, BM; Dillinger, AE; Goepferich, A; Tamm, ER | 1 |
| Chen, F; Wang, P; Zhang, X | 1 |
| Bzoma, B; Dębska-Ślizień, A; Glasner, L; Raczyńska, D; Raczyńska, K; Ślizień, M | 1 |
| Akpek, EK; Smith, RA | 1 |
| Cardarelli, WJ; Smith, RA | 1 |
| Arnon, R; Goldis, M; Regelmann, MO | 1 |
| Cui, J; Li, DQ; Qiu, MC; Zhang, JS; Zhang, P; Zhang, X | 1 |
| Chen, J; Du, M; Fu, D; Hammad, SM; Lyons, TJ; Wilson, K; Wu, M; Yang, S; Zhang, J | 1 |
| Chen, XM; Fang, YH; Lei, B; Shen, Q; Zhang, XD; Zong, YJ | 1 |
| Dequiedt, P; Fontaine, P; Guillem, P; Pruvot, FR; Vlaeminck-Guillem, V | 1 |
| Heering, P; Rossa, V; Schmitt-Gräff, A; Sundmacher, R | 1 |
3 review(s) available for cyclosporine and Diabetic Retinopathy
| Article | Year |
|---|---|
Current treatment strategies for age-related ocular conditions.
Topics: Aged; Antibodies, Monoclonal, Humanized; Bevacizumab; Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus; Diabetic Retinopathy; Disease Progression; Dry Eye Syndromes; Glaucoma; Glycated Hemoglobin; Humans; Macular Degeneration; Medication Adherence; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Vascular Endothelial Growth Factor A | 2013 |
Managed care implications of age-related ocular conditions.
Topics: Aged; Antibodies, Monoclonal, Humanized; Bevacizumab; Clinical Trials as Topic; Cyclosporine; Diabetic Retinopathy; Drug Costs; Dry Eye Syndromes; Glaucoma, Open-Angle; Humans; Laser Therapy; Medicare; Medication Adherence; Ranibizumab; Severity of Illness Index; United States; Vascular Endothelial Growth Factor A; Vision Disorders; Wet Macular Degeneration | 2013 |
New-onset diabetes mellitus after pediatric liver transplantation.
Topics: Albuminuria; Child; Cyclosporine; Diabetes Mellitus; Diabetic Retinopathy; Glucocorticoids; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Insulin; Liver Failure; Liver Transplantation; Metformin; Pediatrics; Risk Factors; Sirolimus; Tacrolimus | 2015 |
8 other study(ies) available for cyclosporine and Diabetic Retinopathy
| Article | Year |
|---|---|
Intravenous injection of cyclosporin A loaded lipid nanocapsules fights inflammation and immune system activation in a mouse model of diabetic retinopathy.
Topics: Animals; Cyclosporine; Cytokines; Diabetes Mellitus; Diabetic Retinopathy; Disease Models, Animal; Humans; Immune System; Inflammation; Injections, Intravenous; Lipids; Nanocapsules | 2023 |
Cyclosporine-a attenuates retinal inflammation by inhibiting HMGB-1 formation in rats with type 2 diabetes mellitus.
Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Retinopathy; HMGB1 Protein; Interleukin-1beta; Intravitreal Injections; Male; Rats, Sprague-Dawley; Retina; Tumor Necrosis Factor-alpha | 2020 |
A 10-year monitoring of the eyesight in patients after kidney transplantation.
Topics: Adult; Cataract; Cyclosporine; Diabetic Retinopathy; Female; Humans; Hypertensive Retinopathy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pilot Projects; Poland; Postoperative Complications; Postoperative Period; Risk Factors; Tomography, Optical Coherence; Tonometry, Ocular; Visual Acuity | 2018 |
[The effects of cyclosporine A on immunoglobulins deposition in retina of streptozotocin-induced diabetic rats].
Topics: Animals; Cyclosporine; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Immunosuppressive Agents; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Retina; Streptozocin | 2008 |
Mechanisms of modified LDL-induced pericyte loss and retinal injury in diabetic retinopathy.
Topics: Acetylcysteine; Activating Transcription Factor 6; Apolipoproteins B; Apoptosis; Autophagy; Butylamines; Cell Survival; Cells, Cultured; Cyclosporine; Diabetic Retinopathy; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Enzyme Inhibitors; Glycosylation; Heat-Shock Proteins; Humans; Lipid Peroxidation; Lipoproteins, LDL; Mitochondria; Oxidative Stress; Pericytes; Poly I; Retina; Retinal Vessels | 2012 |
[The protective effects on the function and structure of retinae in diabetic rats by intravitreal injection of cyclosporin A].
Topics: Animals; Cyclosporine; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Intravitreal Injections; Male; Rats; Rats, Sprague-Dawley; Retina | 2012 |
Liver transplantation eliminates insulin needs of a diabetic patient.
Topics: Aged; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Glomerulonephritis; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Insulin; Kidney Failure, Chronic; Liver Transplantation; Middle Aged; Postoperative Period | 2000 |
[Clinical follow-up, histologic findings and therapeutic problems in a patient with bilateral ulcus rodens Mooren].
Topics: Adult; Cataract Extraction; Cornea; Corneal Opacity; Corneal Stroma; Corneal Ulcer; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Humans; Keratoplasty, Penetrating; Male; Ophthalmic Solutions; Postoperative Complications | 1991 |